The Abuse Liability of IQOS Heated Tobacco Products Among Adults Who Smoke
Studying User Sensory Experiences and Smoking Behavior of IQOS Heated Tobacco Products to Improve Harm Reduction Among Adult Cigarette Smokers
研究概览
详细说明
PRIMARY OBJECTIVES:
I. Assess the abuse liability (appeal and sensory effects) of IQOS. II. Examine the puffing topography of IQOS.
SECONDARY OBJECTIVES:
I. Evaluate the impact of flavor on the sensory effects, appeal, and puffing topography of IQOS.
II. Evaluate the effect of perceived harm on IQOS use behavior.
EXPLORATORY OBJECTIVE:
I. Examine acute changes to pulmonary health associated with IQOS use.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants use IQOS HeatSticks (flavor matched to their usual cigarette) as much as desired (ad lib) over 60 minutes during laboratory visit 1. At least forty-eight hours later, participants smoke their usual brand cigarette (UBC) ad lib over 60 minutes during laboratory visit 2.
ARM II: Participants smoke their UBC ad lib over 60 minutes during laboratory visit 1. At least forty-eight hours later, participants use IQOS HeatSticks (flavor matched to their usual cigarette) ad lib over 60 minutes during laboratory visit 2.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:The Ohio State University Comprehensive Cancer Center
- 电话号码:800-293-5066
- 邮箱:OSUCCCClinicaltrials@osumc.edu
学习地点
-
-
Ohio
-
Columbus、Ohio、美国、43210
- 招聘中
- Ohio State University Comprehensive Cancer Center
-
首席研究员:
- Alayna P. Tackett, PhD
-
接触:
- Alayna P. Tackett, PhD
- 电话号码:844-744-2447
- 邮箱:Tackett-Lab@osumc.edu
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Adults 21-65 years
- Adults who smoke (defined as ≥ 5 days weekly use of either menthol or non-menthol cigarettes over the past 3 months)
- Willing to provide informed consent and abstain from using nicotine products 12 hours before each visit
- Willing to bring UBC to each study visit
- Read, write and speak English
Exclusion Criteria:
- Current use of other non-combustible nicotine products (e.g., electronic [e]-cigarettes, HTPs; [defined as ≥ 5 days weekly use in the past 30 days])
- Planning to quit nicotine use and/or use of any smoking cessation medication in the past 30 days
- Current diagnosis of any lung diseases (e.g., asthma, cystic fibrosis, or chronic obstructive pulmonary disease)
- Self-reported unstable or significant psychiatric conditions (past/stable conditions will be allowed)
- History of cardiac event or distress within the past 3 months
- Deaf, hard of hearing, or have a severe motor disability
- Are currently pregnant, planning to become pregnant, or breastfeeding (urine pregnancy test will be completed at each visit throughout the study)
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
其他:Arm I (IQOS HeatSticks, Usual Brand Cigarette [UBC])
Participants use IQOS HeatSticks (flavor matched to their usual cigarette) ad lib over 60 minutes during laboratory visit 1.
At least forty-eight hours later, participants smoke their UBC ad lib over 60 minutes during laboratory visit 2.
|
Use IQOS HeatSticks (flavor matched to the participant's usual cigarette)
Smoke UBC
|
|
其他:Arm II (UBC, IQOS HeatSticks)
Participants smoke their UBC ad lib over 60 minutes during laboratory visit 1.
At least forty-eight hours later, participants use IQOS HeatSticks (flavor matched to their usual cigarette) ad lib over 60 minutes during laboratory visit 2.
|
Use IQOS HeatSticks (flavor matched to the participant's usual cigarette)
Smoke UBC
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Product Appeal
大体时间:Minute 5 of product use session, Minute 35 of product use session, Minute 60 of product use session
|
Participants will complete the Appeal and Sensory Quality questionnaire.
This questionnaire will ask participants to rate each study product for appeal characteristics such as liking, willingness to use again, flavor intensity, pleasantness of taste, etc. on a scale of 0 (not at all) - 100 (extremely).
Higher scores indicate greater liking, willingness to use again, flavor intensity, etc.
|
Minute 5 of product use session, Minute 35 of product use session, Minute 60 of product use session
|
|
Product Sensory Attributes
大体时间:Minute 5 of product use session, Minute 35 of product use session, Minute 60 of product use session
|
Participants will rate sensory attributes using the Appeal and Sensory Quality questionnaire.
This questionnaire will ask participants to rate each study product for sensory attributes such as harshness, coolness, sweetness, etc. on a scale of 0 (not at all) - 100 (extremely).
Higher scores indicate greater harshness, coolness, sweetness, etc.
|
Minute 5 of product use session, Minute 35 of product use session, Minute 60 of product use session
|
|
Economic demand breakpoint
大体时间:Minute 60 of product use session
|
The price point at which a participant is no longer willing to pay for a stick of the study product will be determined by using a cigarette purchase task questionnaire.
|
Minute 60 of product use session
|
|
Satisfaction and psychological reward
大体时间:Minute 5 of product use session, Minute 35 of product use session, Minute 60 of product use session
|
Satisfaction and psychological reward of study product use will be measured by the Modified Cigarette Evaluation Questionnaire (mCEQ).
The mCEQ asks questions relating to satisfaction of using the study product on a scale from 0 (Not at all) - 6 (Extremely).
|
Minute 5 of product use session, Minute 35 of product use session, Minute 60 of product use session
|
|
Abuse Liability Via Puff Topography - Total Smoking Time
大体时间:Minute 60 of product use session
|
Will be measured with a topography device that records frequency, duration, and flow rate of cigarette puffs.
These measures are combined to inform overall cigarette puff behavior.
|
Minute 60 of product use session
|
|
Abuse Liability Via Puff Topography - Average Puff Duration
大体时间:Minute 60 of product use session
|
Will be measured with a topography device that records frequency, duration, and flow rate of cigarette puffs.
These measures are combined to inform overall cigarette puff behavior.
|
Minute 60 of product use session
|
|
Abuse Liability Via Puff Topography - Average Flow Rate
大体时间:Minute 60 of product use session
|
Will be measured with a topography device that records frequency, duration, and flow rate of cigarette puffs.
These measures are combined to inform overall cigarette puff behavior.
|
Minute 60 of product use session
|
|
Abuse Liability Via Puff Topography - Average Inter-Puff Interval
大体时间:Minute 60 of product use session
|
Will be measured with a topography device that records frequency, duration, and flow rate of cigarette puffs.
These measures are combined to inform overall cigarette puff behavior.
|
Minute 60 of product use session
|
|
Abuse Liability Via Puff Topography - Average Puff Volume
大体时间:Minute 60 of product use session
|
Will be measured with a topography device that records frequency, duration, and flow rate of cigarette puffs.
These measures are combined to inform overall cigarette puff behavior.
|
Minute 60 of product use session
|
|
Craving/withdrawal
大体时间:Minute 0 before product use session, Minute 5 of product use session, Minute 35 of product use session, minute 60 of product use session
|
Nicotine withdrawal and craving symptoms will be measured using the Minnesota Nicotine Withdrawal Scale (MNWS)
|
Minute 0 before product use session, Minute 5 of product use session, Minute 35 of product use session, minute 60 of product use session
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Spirometry FEV1
大体时间:Minute 0 before start of product use session and minute 60 of product use session
|
Spirometry will be used to measure forced expiratory volume (FEV1)
|
Minute 0 before start of product use session and minute 60 of product use session
|
|
Spirometry FVC
大体时间:Minute 0 before start of product use session, Minute 60 of product use session
|
Spirometry will be used to measure forced vital capacity (FVC)
|
Minute 0 before start of product use session, Minute 60 of product use session
|
|
Spirometry FEV1/FVC
大体时间:Minute 0 before start of product use session, Minute 60 of product use session
|
Spirometry will be used to measure FEV1/FVC
|
Minute 0 before start of product use session, Minute 60 of product use session
|
|
Used filter count
大体时间:Minute 60 of product use session
|
Will assess the number of study product consumed
|
Minute 60 of product use session
|
|
Harm Perception
大体时间:Minute 60 of product use session
|
A harm perception questionnaire will be used to assess the relative and absolute perceived harm of IQOS products.
|
Minute 60 of product use session
|
合作者和调查者
调查人员
- 首席研究员:Alayna P Tackett, PhD、Ohio State University Comprehensive Cancer Center
出版物和有用的链接
有用的网址
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- OSU-26080
- U54CA287392 (美国 NIH 拨款/合同)
- NCI-2026-04495 (注册表标识符:CTRP (Clinical Trial Reporting Program))
- STUDY20260624 (其他标识符:Ohio State University Comprehensive Cancer Center)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.